Immune Checkpoint Inhibitors in Hodgkin Lymphoma
Sort by:
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: HL
FEATURING
Alex Herrera
- 126 views
- October 19, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Treatment of HL in Older Adults
FEATURING
Jonathan Friedberg
- 69 views
- October 19, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Response Adapted Therapy in cHL
FEATURING
Catherine Diefenbach
- 30 views
- October 17, 2023
Total Health
2023 ASCO® Direct Philadelphia: Hodgkin Lymphoma Updates
FEATURING
Jakub Svoboda
- 171 views
- September 29, 2023
- 1
SOHO Turkey 2023
SOHO Turkey 2023: How I Treat Hodgkin Lymphoma
FEATURING
Tayfur Toptas
- 85 views
- August 24, 2023
- 2
UNC Lineberger Comprehensive Cancer Center
Hodgkin Lymphoma Management: Updates for 2023
FEATURING
Natalie Grover
- 225 views
- July 25, 2023
- 2
MyCancerHaven
Overview of the Diagnosis and Treatment of Hodgkin Lymphoma
FEATURING
Ravi Vij,
Timothy Fenske
- 72 views
- July 6, 2023
- 1
ecancer
ASCO® 2023 Insights: "S1826 Study Summary - Nivolumab-AVD vs. Brentuximab Vedotin-AVD in Pts With Advanced Stage HL"
FEATURING
Alex Herrera
- 73 views
- June 14, 2023
Indy Hematology Review
Jumping on a Moving Bullet Train: Emerging Treatments for Hodgkin Lymphoma
FEATURING
Matthew Lunning
- 77 views
- April 19, 2023
- 1
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient
Updates in Management of Hodgkin Lymphoma
FEATURING
Jakub Svoboda
- 123 views
- February 14, 2023
ASH 2022 Conference Coverage
ASH 2022 Results of the Phase II Radvax Trial: Low-Dose RT With Nivo in Patients With R/R Hodgkin Lymphoma
FEATURING
Michael LaRiviere
- 50 views
- December 16, 2022
SOHO Highlights: State of the Art and Next Questions
SOHO Highlights - State of the Art & Next Questions: Hodgkin Lymphoma
FEATURING
Nancy Bartlett
- 351 views
- December 6, 2022
- 1
University of Colorado Department of Medicine
Immunotherapy in Lymphomas: The Present and the Future
FEATURING
Manali Kamdar
- 860 views
- September 7, 2022
- 6
SOHO Brazil 2022
SOHO Brazil 2022 on CPIs in Hodgkin Lymphoma: Recent Progress
FEATURING
Philippe Armand,
Alvaro Alencar
- 67 views
- August 31, 2022
UChicago Medicine
Update on Immunotherapy Efforts in cHL and DLBCL
FEATURING
Justin Kline
- 222 views
- August 19, 2022
- 1
19th Annual International Ultmann Chicago Lymphoma Symposium
Impact of the Immune Landscape on Hodgkin Lymphoma Prognosis and Treatment
FEATURING
Christian Steidl
- 112 views
- July 11, 2022
- 1
Penn Medicine Abramson Cancer Center
Therapeutic Advances in Hodgkin Lymphoma
FEATURING
Jakub Svoboda
- 123 views
- May 6, 2022
UNC Lineberger Comprehensive Cancer Center
Latest Advances in the Management of R/R cHL: The Era of Novel Therapies
FEATURING
Natalie Grover
- 163 views
- March 23, 2022
- 1